Park Ha Biological Technology is trading 19.7% down at $2.20 after opening-session selling on September 16, 2026.

  • No credible company-specific announcement dated September 16 was identified.
  • Recent searchable coverage concerns older partnership, financing, and Amazon-store updates, rather than a new catalyst.
  • Broader indexes gained, while biotech-sector weakness does not explain the opposite-direction move; the catalyst remains unclear.